202 related articles for article (PubMed ID: 26045835)
1. Association between COX-2 polymorphisms and non-small cell lung cancer susceptibility.
Zhang T; Li J; Xia T; Zhang N; Zhang Y; Zhao J
Int J Clin Exp Pathol; 2015; 8(3):3168-73. PubMed ID: 26045835
[TBL] [Abstract][Full Text] [Related]
2. Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non-small-cell lung cancer.
Kuo WH; Shih CM; Lin CW; Cheng WE; Chen SC; Chen W; Lee YL
Transl Res; 2012 Jan; 159(1):42-50. PubMed ID: 22153809
[TBL] [Abstract][Full Text] [Related]
3. Relationship between genetic polymorphisms of DNA ligase 1 and non-small cell lung cancer susceptibility and radiosensitivity.
Tian H; He X; Yin L; Guo WJ; Xia YY; Jiang ZX
Genet Mol Res; 2015 Jun; 14(2):7047-52. PubMed ID: 26125914
[TBL] [Abstract][Full Text] [Related]
4. Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies.
Li Q; Liu L; Liu Y; Zhou H; Yang Z; Yuan K; Min W
Med Oncol; 2015 Jan; 32(1):397. PubMed ID: 25433948
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
6. The association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapy.
Zhou F; Gao G; Ren S; Li X; He Y; Zhou C
PLoS One; 2013; 8(4):e61585. PubMed ID: 23620771
[TBL] [Abstract][Full Text] [Related]
7. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
8. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
10. Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese.
Guo S; Li X; Gao M; Kong H; Li Y; Gu M; Dong X; Niu W
PLoS One; 2012; 7(6):e39814. PubMed ID: 22761909
[TBL] [Abstract][Full Text] [Related]
11. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
12. Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4.
Gomes M; Coelho A; Araújo A; Teixeira AL; Catarino R; Medeiros R
Gene; 2012 Aug; 504(1):111-5. PubMed ID: 22583827
[TBL] [Abstract][Full Text] [Related]
13. STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer.
Jiang B; Zhu ZZ; Liu F; Yang LJ; Zhang WY; Yuan HH; Wang JG; Hu XH; Huang G
Genet Mol Res; 2011 Aug; 10(3):1856-65. PubMed ID: 21948749
[TBL] [Abstract][Full Text] [Related]
14. COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.
Li J; Lu X; Zou X; Jiang Y; Yao J; Liu H; Ni B; Ma H
Medicine (Baltimore); 2018 Aug; 97(35):e11859. PubMed ID: 30170377
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies.
Xu W; Huang Y; Zhang T; Zhao L; Fan J; Li L
J Cancer Res Ther; 2018; 14(Supplement):S105-S113. PubMed ID: 29578159
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 (COX-2) polymorphism rs689466 may contribute to the increased susceptibility to post-traumatic osteomyelitis in Chinese population.
Wang L; Jiang N; Lin QR; Qin CH; Hu YJ; Yu B
Infect Dis (Lond); 2017; 49(11-12):817-823. PubMed ID: 28682162
[TBL] [Abstract][Full Text] [Related]
18. MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer.
Pan JH; Han JX; Wu JM; Sheng LJ; Huang HN; Yu QZ
Respiration; 2008; 75(4):380-5. PubMed ID: 17851225
[TBL] [Abstract][Full Text] [Related]
19. Genetic Polymorphisms in the Apoptosis-Associated Gene CASP3 and the Risk of Lung Cancer in Chinese Population.
Lin J; Zhang Y; Wang H; Chang J; Wei L; Cao L; Zhang Z; Zhang X
PLoS One; 2016; 11(10):e0164358. PubMed ID: 27723786
[TBL] [Abstract][Full Text] [Related]
20. Role of GSTP1 Ile105Val and XRCC1 Arg194Trp, Arg280His and Arg399Gln gene polymorphisms in the clinical outcome of advanced non-small cell lung cancer.
Zhao R; Chen G
Int J Clin Exp Pathol; 2015; 8(11):14909-16. PubMed ID: 26823821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]